TrialFrontiers in medicine2026

Safe prolonged prophylactic use and tolerability of Ashwagandha following COVISHIELD™ vaccination over 24 weeks: a multicentre randomized double-blind placebo-controlled trial.

Arvind Chopra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.